ASPIRE Randomized Clinical Trial

What is ASPIRE ?

Burke became the first inpatient rehabilitation facility-based recruitment site for Anticoagulation for Stroke Prevention and Recovery after Intracerebral Hemorrhage (ASPIRE) trial within the National Institutes of Health StrokeNet Collaborative. 

Trial Objective

Clinical Trial Details

This clinical trial aims to determine if apixaban is better at aspirin in preventing another stroke in patients who had a stroke and are diagnosed with atrial fibrillation (AF).

Principal Investigator

Dr. Kathryn Kirchoff

Do I Qualify?

You may qualify if:

• You are 18 or older
• You had bleeding in your brain (intracerebral or intraventricular hemorrhage), and a CT scan or MRI showed it
• Your brain bleed happened between 2 weeks and 6 months ago
• You have a heart condition called atrial fibrillation or atrial flutter

Learn More about the ASPIRE Randomized Clinical Trial [PDF]

Contact

Burke Rehabilitation at Burkeclinicalresearch@burke.org

Location

Burke Rehabilitation
785 Mamaroneck Avenue
White Plains, NY 10605